Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: basic and clinical studies.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Brain Research Bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0361-9230(96)00010-XPMID 8722748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra

  2004cited by this paper
• Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior

  2004cited by this paper
• Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat

  2004cited by this paper
• Survival of dissociated adrenal chromaffin cells of rat and monkey transplanted into rat brain

  2004cited by this paper
• Unfavorable outcome of adrenal medullary transplant for Parkinson's disease

  2004cited by this paper
• Long-term effects of dexamethasone and nerve growth factor on adrenal medullary cells cultured from young adult rats

  2004cited by this paper
• Histological signs of immune reactions against allogeneic solid fetal neural grafts in the mouse cerebellum depend on the MHC locus

  2004cited by this paper
• Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons

  2004cited by this paper
• Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture

  2004cited by this paper
• Comparison of adrenal and foetal nigral grafts on drug-induced rotation in rats with 6-OHDA lesions

  2004cited by this paper
• Ultrastructural evidence for the development of adrenal medullary grafts in the brain

  2004cited by this paper
• Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report.

  1996cited by this paper
• Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting.

  1996cited by this paper
• Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats.

  1996cited by this paper
• Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation.

  1995cited by this paper
• Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

  1995cited by this paper
• Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat.

  1995cited by this paper
• Intrastriatal cografts of autologous adrenal medulla and sural nerve in MPTP-induced parkinsonian macaques: behavioral and anatomical assessment.

  1995cited by this paper
• Enhanced survival and neuronal differentiation of adrenal chromaffin cells cografted into the striatum with NGF-producing fibroblasts

  1995cited by this paper
• GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.

  1995cited by this paper
• Chromaffin cell survival prolonged by nerve growth factor from pretransected sciatic nerve.

  1995cited by this paper
• Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

  1995cited by this paper
• Two-year follow-up study of a patient with Parkinson's disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report.

  1995cited by this paper
• Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease.

  1994cited by this paper
• Cografts of Adrenal Medulla with Peripheral Nerve for Parkinson's Disease

  1994cited by this paper
• Increased nerve growth factor level in the distal stump of transected sciatic nerve in relation to aging and its application for neural grafting.

  1994cited by this paper
• Effect of host age upon the degree of nigrostriatal dopaminergic system recovery following cografts of adrenal medulla and pretransected peripheral nerve.

  1994cited by this paper
• Dose-dependent effects of recombinant human NGF on grafted adult adrenal medullary tissue.

  1994cited by this paper
• TRANSPLANTATION IN HUMANS OF ENCAPSULATED XENOGENEIC CELLS WITHOUT IMMUNOSUPPRESSION: A PRELIMINARY REPORT

  1994cited by this paper
• Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.

  1994cited by this paper
• CNTF is superior to NGF as a survival enhancement factor for adrenal medulla cells in vitro.

  1994cited by this paper
• Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases

  1994cited by this paper
• Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

  1994cited by this paper
• Four-year follow-up of adrenal-to-brain transplants in Parkinson's disease.

  1994cited by this paper
• Immunological reactions following intracerebroventricular transplantation of adrenal medulla

  1994cited by this paper
• Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation.

  1994cited by this paper
• Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease.

  1994cited by this paper
• Trophic factors from chromaffin granules promote survival of peripheral and central nervous system neurons.

  1994cited by this paper
• Brain and spinal cord revascularization by omental transposition.

  1994cited by this paper
• Functional neural transplantation

  1994cited by this paper
• Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity.

  1994cited by this paper
• The Biology and Behaviour of Intracerebral Adrenal Transplants in Animals and Man

  1993cited by this paper
• Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability

  1993cited by this paper
• The effect of a short-course treatment with FK506 on the survivability of rat-to-mouse cross-species neural graft

  1993cited by this paper
• Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging.

  1993cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• Neurotransplantation: a clinical update.

  1993cited by this paper
• Mouse adrenal chromaffin cells can transform to neuron-like cholinergic phenotypes after being grafted into the brain

  1993cited by this paper
• Developing a stable bilateral model of parkinsonism in rhesus monkeys.

  1993cited by this paper
• Suppression of immunorejection against rat fetal dopaminergic neurons in a mouse brain by 15-deoxyspergualin.

  1993cited by this paper
• The influence of donor age on cografting of adrenal medulla with pretransected peripheral nerve.

  1993cited by this paper
• Long-term effects of cografts of pretransected peripheral nerve with adrenal medulla in animal models of Parkinson's disease.

  1993cited by this paper
• Subarachnoid Adrenal Medullary Transplants for Terminal Cancer Pain A Report of Preliminary Studies

  1993cited by this paper
• A descriptive and quantitative morphometric study of long-term mouse adrenal medulla grafts implanted into the putamen: effect of nerve growth factor injected at grafting.

  1993cited by this paper
• Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.

  1993cited by this paper
• Immunohistochemical Identification of Rat Adrenal Cortical Tissue in Situ, in Vitro, and in Intracerebral Adrenal Grafts

  1993cited by this paper
• The trophic cocktail made by adrenal chromaffin cells.

  1993cited by this paper
• Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease.

  1993cited by this paper
• Certain host-donor strain combinations do not reject brain allografts after systemic sensitization.

  1993cited by this paper
• Xenogeneic dopaminergic grafts reverse behavioral deficits induced by 6-OHDA in rodents: effect of 15-deoxyspergualin treatment.

  1993cited by this paper
• Effects of adrenal medulla grafts on plasma catecholamines and rotational behavior.

  1992cited by this paper
• Core assessment program for intracerebral transplantations (CAPIT)

  1992cited by this paper
• Long-term Follow-up of Adrenal Medullary Transplantation for Parkinson's Disease

  1992cited by this paper
• The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat.

  1992cited by this paper
• Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's disease

  1992cited by this paper
• Development of human neural transplantation.

  1992cited by this paper
• Short-Term Immunosuppression Enhances Long-Term Survival of Bovine Chromaffin Cell Xenografts in Rat Cns

  1992cited by this paper
• Screening of adrenal medullary neuropeptides for putative neurotrophic effects

  1992cited by this paper
• Polymer encapsulated neurotransmitter secreting cells. Potential treatment for Parkinson's disease.

  1992cited by this paper
• Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.

  1992cited by this paper
• Chromaffin cell transplants for alleviation of chronic pain.

  1992cited by this paper
• Recovery in hemiparkinsonian rats following intrastriatal implantation of activated leukocytes.

  1992cited by this paper
• The chromogranins A and B: The first 25 years and future perspectives

  1992cited by this paper
• Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

  1992cited by this paper
• Peripheral nerve segments promote consistent long-term survival of adrenal medulla transplants in the brain.

  1992cited by this paper
• A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy.

  1992cited by this paper
• Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's disease. CHP Neural Transplantation Group.

  1992cited by this paper
• Development of Human Neural Transplantation

  1991cited by this paper
• United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants

  1991cited by this paper
• Adrenal medullary "ribbon" grafts in non-human primates: transplant method.

  1991cited by this paper
• BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

  1991cited by this paper
• Grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. Clinica Puerta de Hierro Neural Transplantation Group.

  1991cited by this paper
• Stereotaxic injection of GD1a ganglioside induces limited recovery of striatal dopaminergic system in MPTP‐treated aging mice

  1991cited by this paper
• The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft.

  1991cited by this paper
• Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial.

  1991cited by this paper
• Stereotaxic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism. One-year follow-up.

  1991cited by this paper
• Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid.

  1991cited by this paper
• The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum.

  1991cited by this paper
• The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents.

  1991cited by this paper
• BN rats do not reject F344 brain allografts even after systemic sensitization

  1991cited by this paper
• Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla.

  1991cited by this paper
• Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain.

  1991cited by this paper
• Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: inhibition by antibodies to NGF.

  1991cited by this paper
• EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture

  1991cited by this paper
• Transplantation of adrenal medulla and omentum to the putamen by a transinsular pathway for Parkinson's disease.

  1991cited by this paper
• Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen.

  1991cited by this paper
• Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats.

  1991cited by this paper
• Putative chromaffin cell survival and enhanced host‐derived TH‐Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease

  1991cited by this paper
• The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685]

  1991cited by this paper
• Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned rat.

  1991cited by this paper

• Implantation of glial cell line-derived neurotrophic factor-expressing adipose tissue-derived stromal cells in a rat Parkinson’s disease model

  2020cites this paper
• Fibroblast Growth Factors

  2019cites this paper
• Potentiel thérapeutique de neurones dopaminergiques dérivés de cellules souches embryonnaires de souris dans un modèle murin de la maladie de Parkinson

  2017cites this paper
• Therapeutic Effects of Mesenchymal Stem Cells for Parkinson ’ s Disease

  2016cites this paper
• Engineering neural stem cell fates with hydrogel design for central nervous system regeneration

  2012cites this paper
• Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone‐treated parkinsonian mice

  2012cites this paper
• Behavioural analysis of 6-hydroxydopamine rodent models of Parkinson's disease

  2012cites this paper
• 脳神経外科医教育における基礎研究の意義(脳神経外科教育におけるAcademic Skillの確立)

  2011cites this paper
• Significance of basic research in education for neurosurgeons

  2011cites this paper
• Past, Present and Future of Human Chromaffin Cells: Role in Physiology and Therapeutics

  2010cites this paper
• Neurotransmitter and Neurotrophic Factor-Secreting Cell Line Grafting for the Treatment of Parkinson’s Disease

  2008cites this paper
• Terapia celular en la Enfermedad de Parkinson

  2008cites this paper
• Human fetal chromaffin cells: a potential tool for cell pain therapy.

  2007cites this paper
• Cell therapy of pain: Characterization of human fetal chromaffin cells at early adrenal medulla development.

  2006cites this paper
• Manipulation of precursor cells for the replacement of complex circuitry lost in neurodegenerative disease

  2005cites this paper
• Immobilization of Arg-Gly-Asp (RGD) sequence in a thermosensitive hydrogel for cell delivery using pheochromocytoma cells (PC12).

  2004cites this paper
• Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo.

  2004cites this paper
• Synthesis of Arg–Gly–Asp (RGD) Sequence Conjugated Thermo-Reversible Gel via the PEG Spacer Arm as an Extracellular Matrix for a Pheochromocytoma Cell (PC12) Culture

  2004cites this paper
• Lesional and Deep Brain Stimulator Surgery for Essential Tremor and Other Movement Disorders

  2003cites this paper
• Survival and differentiation of adult rat-derived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats.

  2003cites this paper
• パーキンソン病に対する細胞治療―ドパミン・GDNF 産生細胞移植を中心に―

  2003cites this paper
• 12 – Stem Cells of the Nervous System

  2002cites this paper
• Involvement of adrenal medulla grafts in the open field behavior.

  2001cites this paper
• The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.

  2000cites this paper
• Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation.

  2000cites this paper
• Behavioral Evaluation of Hemiparkinsonian MPTP Monkeys following Dopamine Pharmacological Manipulation and Adrenal Co-Graft Transplantation

  2000cites this paper
• Grafting of Encapsulated Dopamine-Secreting Cells in Parkinson's Disease: Long-Term Primate Study

  2000cites this paper
• Effects of graft placement site on the survival of adrenal medulla transplants into the brain and its relation with the recovery of motor function.

  2000cites this paper
• Neural Transplantation for Parkinson's Disease

  1999cites this paper
• Choline Availability Modulates the Expression of TGFβ1 and Cytoskeletal Proteins in the Hippocampus of Developing Rat Brain

  1998cites this paper
• [Neural transplantation and regeneration: current status and future perspective].

  1998cites this paper
• The Use of Neurotoxins to Lesion Catecholamine-Containing Neurons to Model Clinical Disorders

  1998cites this paper
• Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis?

  1998cites this paper
• GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice

  1998cites this paper
• Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells.

  1997cites this paper
• Evaluation of intracerebral grafting of dopamine-secreting PC12 cells into allogeneic and xenogeneic brain.

  1997cites this paper
• Three-dimensional analysis of vasospastic major cerebral arteries in rats with the corrosion cast technique.

  1997cites this paper
• Evaluation of Intracerebral Grafting of Dopamine-Secreting PC12 Cells into Allogeneic and Xenogeneic Brain

  1997cites this paper
• Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.

  1997cites this paper
• Parkinson's disease.

  1996cites this paper